Cdc7-Dbf4 kinase also is an excellent target for therapeutic strategies that not only block DNA synthesis at the beginning but also sensitize cancer cells to DNA damage by targeting HSP90/ATR/ATM, which may a promising approach to enhance the therapeutic effect of radiation or chemotherapy. The gene discussed is ATR; the disease is cancer.